Navigation Links
Telik Announces Presentation and Webcast at UBS Global Life Sciences Conference
Date:9/19/2007

PALO ALTO, Calif., Sept. 19 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK) announced that company management will provide a corporate overview at the UBS Global Life Sciences Conference in New York City on Wednesday, September 26, 2007 at 12:30 p.m. Eastern time (9:30 a.m. Pacific time). Telik's presentation will be webcast live and will be available for replay through the Telik website, http://www.telik.com, through October 3, 2007.

Telik, Inc. of Palo Alto, CA is a biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. The company's most advanced drug development candidates are TELCYTA(R), a tumor-activated small molecule product candidate in clinical development for the treatment of advanced ovarian cancer and non- small cell lung cancer; and TELINTRA(TM), which is in clinical development for the treatment of myelodysplastic syndrome. Telik's product candidates were discovered using its proprietary drug discovery technology, TRAP(TM), which enables the rapid and efficient discovery of small molecule drug candidates.


'/>"/>
SOURCE Telik, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... ... August 23, 2017 , ... ... orders for advanced VPG+ 800 Volume Pattern Generators from two major Asian based ... demand for production of advanced photomasks as well as a solution for mid ...
(Date:8/23/2017)... MN (PRWEB) , ... August 23, 2017 , ... ... by health systems and academic medical centers. The network provides members nationally scaled ... limited-distribution drugs and biologics and restrictive payer agreements so members can provide continuity ...
(Date:8/22/2017)... MN (PRWEB) , ... August 22, 2017 , ... ... on opioids in pain management is the practice of opioid-dose sparing. Opioid-dose sparing ... practice has shown promising results, including with non-steroidal anti-inflammatory drugs (NSAIDs). , The ...
(Date:8/21/2017)... ... 20, 2017 , ... Brian Pogue of Dartmouth has been ... The journal is published by SPIE, the international society for optics and photonics. ... optical technology for improved health care and biomedical research. The journal is published ...
Breaking Biology Technology:
(Date:4/4/2017)... NEW YORK , April 4, 2017   ... solutions, today announced that the United States Patent and ... The patent broadly covers the linking of an iris ... the same transaction) and represents the company,s 45 th ... our latest patent is very timely given the multi-modal ...
(Date:3/30/2017)... , March 30, 2017  On April 6-7, 2017, ... the Genome hackathon at Microsoft,s headquarters in ... competition will focus on developing health and wellness apps ... Hack the Genome is the first hackathon ... The world,s largest companies in the genomics, tech and ...
(Date:3/30/2017)... 30, 2017 Trends, opportunities and forecast in ... by technology (fingerprint, AFIS, iris recognition, facial recognition, hand ... by end use industry (government and law enforcement, commercial ... banking, and others), and by region ( North ... Asia Pacific , and the Rest of ...
Breaking Biology News(10 mins):